SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-011437
Filing Date
2024-04-24
Accepted
2024-04-24 16:15:00
Documents
2
Period of Report
2024-04-22

Document Format Files

Seq Description Document Type Size
1 form3-04242024_080453.html 3  
1 form3-04242024_080453.xml 3 3989
2 ex24-04242024_080454.htm EX-24 8117
  Complete submission text file 0001415889-24-011437.txt   13505
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Adib Deyaa (Reporting) CIK: 0002014286 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36740 | Film No.: 24870742